Position
Squarepoint Ops LLC in Zevra Therapeutics, Inc.
Back to the book · All holders of ZVRA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $65.8K$8.96 → $9.32
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 317.1K | $2.84M | — | — | — | 0.0% |
| Q1 2026 | 182.9K | $1.7M | $9.32 | $65.8K | −$1.2M | 0.0% |